# Nicotinic Acid - Pharmacokinetics, Pharmacodynamics, Receptor Expression

> **NCT00176020** · PHASE1 · UNKNOWN · sponsor: **Heidelberg University** · enrollment: 18 (—)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** nicotinic acid

## Key facts

- **NCT ID:** NCT00176020
- **Lead sponsor:** Heidelberg University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 18 (—)
- **Last updated:** 2006-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00176020

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00176020, "Nicotinic Acid - Pharmacokinetics, Pharmacodynamics, Receptor Expression". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00176020. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*